SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CLZR:a potential 10 bagger?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Ariella who wrote (68)7/31/1998 11:33:00 AM
From: Bob Davis  Read Replies (4) of 315
 
Ariella,

By the way, CLZR was written up in this morning's Wall Street Journal in its "Thursday's Market Activity" report:

"Candela moved up 15/16, or 29%, to 4 3/16, as it earned 19 cents a
share in its fourth quarter, compared with a loss of 24 cents in
the year-earlier period. The company also said it has eliminated
the adverse impact on its earnings from its skin-care center."

This will clearly generate more interest in the stock, as its "market
awareness" has been relatively low.

I participated in yesterday's Analysts Conference Call with the Company, and I now feel that the fourth quarter earnings can be sustained into the future. Although the Company will not have its 10-K Report out for over a month, I plan to update the in-depth Analysis as soon as possible.

Bob Davis
The Napeague Letter
napeague.com

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext